Intellectual property rights “have been indispensable to the development of COVID-19 vaccines, therapeutics, and diagnostics to date,” the Information Technology and Innovation Foundation, a D.C.-based think thank, said in a statement. “ … Endorsing this waiver petition succumbs to the fundamental fallacy that IP rights represent any kind of significant barrier to access and manufacturing of the medicines needed to overcome this crisis.”
